Company Filing History:
Years Active: 1997-1998
Title: Innovations by Franciscus Antonius Rijsewijk
Introduction
Franciscus Antonius Rijsewijk is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of veterinary medicine, particularly in the development of diagnostic tools and vaccines for bovine diseases. With a total of 2 patents, Rijsewijk's work has had a meaningful impact on animal health.
Latest Patents
Rijsewijk's latest patents include innovations related to glycoproteins, antibodies, and diagnostic kits for the detection of bovine herpesvirus type 1. One of his notable inventions is a deletion mutant of bovine herpesvirus type 1, which features a deletion in the glycoprotein gE-gene. This mutant may also include a deletion in the thymidine kinase gene and/or the glycoprotein gI-gene, or it may have an insertion of a heterologous gene. Additionally, he has developed recombinant nucleic acid that comprises the gE-gene or a part thereof, along with glycoprotein gE, peptides based on it, and complexes of glycoproteins gE and gI, as well as antibodies against them. His work also encompasses vaccines and diagnostic kits that utilize these materials.
Career Highlights
Rijsewijk is associated with Stichting Centraal Diergeneeskundig Instituut, where he has been instrumental in advancing research in veterinary virology. His expertise in the field has led to the development of innovative solutions that address critical health issues in livestock.
Collaborations
Rijsewijk has collaborated with esteemed colleagues such as Johannes Theodorus Van Oirschot and Roger K Maes. These partnerships have fostered a collaborative environment that enhances research and development efforts in veterinary medicine.
Conclusion
Franciscus Antonius Rijsewijk's contributions to veterinary science through his patents and collaborations highlight his commitment to improving animal health. His innovative work continues to influence the field positively.